blood stem cells
Showing 1 - 25 of >10,000
Poor Ovarian Response, Infertility, Female Trial in Tehran (Autologous Menstrual Blood Stem Cells)
Completed
- Poor Ovarian Response
- Infertility, Female
- Autologous Menstrual Blood Stem Cells
-
Tehran, Iran, Islamic Republic ofAvicenna Research Institute
Jan 26, 2023
Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run
Recruiting
- Severe Aplastic Anemia (SAA)
- +2 more
- Cyclophosphamide
- Peripheral Blood Stem Cells
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Neonatal Hypoxic-ischaemic Encephalopathy Trial in Marseille (autologous cord blood stem cell)
Recruiting
- Neonatal Hypoxic-ischaemic Encephalopathy
- autologous cord blood stem cell
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Aug 12, 2022
Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)
Active, not recruiting
- Chronic Granulomatous Disease Transplant
- Alemtuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation
Completed
- Leukemia
- +2 more
- CliniMACS Fractionation system (Arm A)
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 12, 2022
Diabetes, Type 1, Immunologic Deficiency Syndromes Trial in Shanghai (Sequential transplantation)
Recruiting
- Diabetes Mellitus, Type 1
- Immunologic Deficiency Syndromes
- Sequential transplantation
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Aug 4, 2022
Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)
Recruiting
- Crohn's Disease
- autologous CD34-selected peripheral blood stem cells transplant
- +8 more
-
Pittsburgh, Pennsylvania
- +1 more
Feb 9, 2022
Cerebral Palsy Trial in Houston (Umbilical Cord Blood Stem Cells, Saline Infusion (Placebo), Bone Marrow Stem Cells)
Completed
- Cerebral Palsy
- umbilical cord blood (hUCB) cells
- +2 more
-
Houston, TexasUTHealth, Medical School, Dept. of Pediatric Surgery
Oct 27, 2022
Xerostomia Following Radiotherapy Trial in Ljubljana (allogeneic mesenchymal stromal stem cells)
Not yet recruiting
- Xerostomia Following Radiotherapy
- allogeneic mesenchymal stromal stem cells
-
Ljubljana, Slovenia
- +3 more
Aug 22, 2023
Cancer Stem Cell Specific Aptamer's Ability to Detect Blood
Completed
- Pancreatic Neoplasm
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 15, 2023
Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and
Recruiting
- Granuloma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Covid19, Cytokine Storm Trial in Tehran (Allogeneic human menstrual blood stem cells secretome, Intravenous saline injection)
Completed
- Covid19
- Cytokine Storm
- Allogeneic human menstrual blood stem cells secretome
- Intravenous saline injection
-
Tehran, Iran, Islamic Republic ofAvicenna Research Institute
Aug 28, 2021
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- sargramostim
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2022
Glioblastoma Trial in Rozzano (18F-GE-180 PET, Advanced MRI, Collection of hematopoietic stem cells)
Not yet recruiting
- Glioblastoma
- 18F-GE-180 PET
- +4 more
-
Rozzano, (mi), ItalyIRCCS Istituto Clinico Humanitas
Oct 27, 2023
Multiple Myeloma Trial in New York (busulfan, melphalan and fludarabine)
Completed
- Multiple Myeloma
- busulfan, melphalan and fludarabine
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 4, 2021
Osteoarthritis, Knee Trial in Ljubljana (Knee aspiration + UCB-MSCs, Knee aspiration)
Recruiting
- Osteoarthritis, Knee
- Knee aspiration + UCB-MSCs
- Knee aspiration
-
Ljubljana, SloveniaUniversity medical centre Ljubljana
Oct 5, 2023
Refractory Diabetic Foot, Human Cord Blood-derived Mononuclear Cells, Efficacy Trial in Nanjing (human cord blood-derived
Recruiting
- Refractory Diabetic Foot
- +4 more
- human cord blood-derived mononuclear cells (HCB-MNCs)
-
Nanjing, Chinathe First Affiliated Hospital of Nanjing Medical University
Aug 13, 2023
Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)
Recruiting
- Chronic Granulomatous Disease
- Sirolimus
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 23, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)
Recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Cyclophosphamide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Cervical Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)
Recruiting
- Cervical Cancer
- Autologous blood transfusion with haematopoietic stem cells
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Sep 13, 2022
Proliferative Potential of H-PBSC Based on Demographics and
Recruiting
- Healthy
- Cellular analysis
-
Gulf Breeze, FloridaAndrews Research & Education Foundation
Oct 6, 2022
Alterations in Intestinal Microbiota, Metabolites, and Immune
Recruiting
- Graft Vs Host Disease
- Blood Sample
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 16, 2023
Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA), Severe Aplastic Anemia (SAA) Trial run by the NHLBI (Umbilical Cord
Completed
- Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)
- Severe Aplastic Anemia (SAA)
- Umbilical Cord Blood
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 16, 2021
Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow
Available
- Benign Neoplasm
- +3 more
- Bone Marrow Transplantation
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 9, 2021
Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell
Completed
- Term and Preterm Neonates (24-41 Weeks Gestational Age)
- Hematopoietic Stem Cell Transplant Recipient Children
- Tubes fund recovery blood count
- the rest of the blood test and stool sample
-
Paris, FranceHôpital Robert Debré
Feb 2, 2023